Company / Operating Income per Share
Tonix Pharmaceuticals Holding Corp. Operating Income per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$31.17
FY2025
5-year range
-$5657.08 / -$9.06
FY2023-FY2025
Trend
+99.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-9.06 to $-31.17 over the past 2 years.
Based on SEC 10-K filings.
-31.17 in FY2025.
Declined from $-9.06 to $-31.17 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 99.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$31.17 | +99.4% |
| FY2024 | -$5657.08 | -62322.7% |
| FY2023 | -$9.06 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 28, 2026